CORC

浏览/检索结果: 共7条,第1-7条 帮助

已选(0)清除 条数/页:   排序方式:
BIM Deletion Polymorphism Confers Resistance to Osimertinib in EGFR T790M Lung Cancer: a Case Report and Literature Review 期刊论文
TARGETED ONCOLOGY, 2018, 卷号: 13, 期号: 4, 页码: 517-523
作者:  Li, Xuanzong;  Wang, Shijiang;  Li, Butuo;  Wang, Zhen;  Shang, Shuheng
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/11
Clinical Implications of the BIM Deletion Polymorphism in Advanced Lung Adenocarcinoma Treated With Gefitinib 期刊论文
CLINICAL LUNG CANCER, 2018, 卷号: 19, 期号: 4, 页码: E431-E438
作者:  Yuan, Jupeng;  Li, Bo;  Zhang, Nasha;  Zhu, Hui;  Zhou, Liqing
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/11
Mimicking the BIM BH3 domain overcomes resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer 期刊论文
ONCOTARGET, 2017, 卷号: 8, 期号: 65
作者:  Xia, Jinjing;  Bai, Hao;  Yan, Bo;  Li, Rong;  Shao, Minhua
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/05
Exploratory cohort study and meta-analysis of BIM deletion polymorphism in patients with epidermal growth factor receptor-mutant non-small-cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors 期刊论文
ONCOTARGETS AND THERAPY, 2017, 卷号: 10
作者:  Sun, Si;  Yu, Hui;  Wang, Huijie;  Zhao, Xinmin;  Zhao, Xintai
收藏  |  浏览/下载:9/0  |  提交时间:2019/12/05
Real-time PCR assay with high resolution melting for EGFR and BIM mutation of lung cancer 期刊论文
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2016, 卷号: 20, 期号: 13
作者:  Xia, J. -J.;  Zhao, S. -F.;  Xiong, L. -W.;  Chu, T. -Q.;  Bai, H.
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/05
Association between BIM deletion polymorphism and the risk of non-small cell lung cancer in Chinese 期刊论文
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 卷号: 9, 期号: 5
作者:  Xia, Jinjing;  Xiong, Liwen;  Chu, Tianqing;  Ye, Junyi;  Bai, Hao
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/13
BIM deletion polymorphism predicts survival in advanced non-small-cell lung cancer 会议论文
作者:  Zhang, X.;  Zhang, L.
收藏  |  浏览/下载:1/0  |  提交时间:2019/12/13


©版权所有 ©2017 CSpace - Powered by CSpace